Metoclopramide Hydrochloride Metoclopramide Hydrochloride 5mg/5ml Oral Solution (Metoclopramide Hydrochloride)

The drug blocks dopamine D2 receptors in the chemoreceptor trigger zone, reducing the vomiting reflex, and also stimulates gastrointestinal motility through 5‑HT4 receptor agonism and mild anticholinergic activity, which together enhance gastric emptying.

The appropriate dose is determined by the prescribing healthcare professional based on the patient’s condition, age, renal function and other clinical factors. Dosing instructions are provided on the prescription label.

Safety data for Metoclopramide in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

Enquiries are submitted via the product page on gnhindia.com, where you specify the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metoclopramide differs from pure serotonin antagonists (e.g., ondansetron) by also promoting gastric motility. It is often chosen when delayed gastric emptying contributes to symptoms, whereas agents without pro‑kinetic activity may be preferred if dopamine antagonism is contraindicated.

Store the oral solution at ambient temperature below 25 °C, in its original container, protected from moisture and direct sunlight. Keep the bottle tightly closed when not in use and discard any solution that appears discoloured or cloudy.

The solution is taken by mouth, usually measured with a calibrated syringe or dosing cup. It may be given with or without food, according to the prescribing information, and the exact timing should follow the healthcare provider’s instructions.

Serious adverse effects include extrapyramidal reactions such as dystonia, tardive dyskinesia with prolonged use, neuroleptic malignant syndrome, severe depression or suicidal thoughts, seizures, and cardiac arrhythmias. Immediate medical attention is required if any of these occur.

Metoclopramide is contraindicated in patients with known hypersensitivity to the drug, those with a history of seizure disorders, severe gastrointestinal obstruction, pheochromocytoma, or in individuals taking other dopamine antagonists that could increase the risk of extrapyramidal symptoms.